| Price and Chart delayed at least 15 mintues. |
|
Price
$ 46.73
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
46.73
|
Volume
NA
|
|
Market Value
22 bil
|
P/E Ratio
82.0
|
|
Bid
45.00
|
EPS
0.57
|
|
Ask
47.97
|
Dividend
0.00
|
|
High
0.00
|
Yield
0.0
|
|
Low
0.00
|
Shares Out
460 mil
|
|
52wk High
77.39
|
52wk Low
36.90
|
|
Industry: Biotechnology
|
|
Sector: Healthcare
|
CELG Profile
A biopharmaceutical company, which is engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
Celgene Corp.
86 Morris Avenue
Summit, NJ 07901
Phone: (908) 673-9000
Fax: (908) 673-9001
Web Site: www.celgene.com
CELG Wires Headlines
|
|
| 07.02.09 |
|
Final Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Midday Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Early Glance: Biotechnology companies
|
|
| 07.01.09 |
|
Final Glance: Biotechnology companies
|
|
| 07.01.09 |
|
Midday Glance: Biotechnology companies
|
More CELG From Wires Headlines >
Forbes.com on CELG RSS
No news found in the past 30 days.
Investopedia on CELG
|